Guanfacine is a popular second-line treatment for ADHD in children and teens. But what happens as our patients age into adulthood? Does guanfacine remain an effective medication in adults with ADHD? This research update covers a study that tries to answer this question.

How long should you wait before making changes after initiating an antipsychotic? The current study tested if early efficacy on an antipsychotic predicts subsequent efficacy, and its findings indicate benefits may be observed as quickly as two weeks. 

Does physical activity help relieve depression in children and adolescents? We know it helps adults, but what is the evidence in kids? This research update looks at a study that tries to elucidate the effectiveness of exercise on depression in kids and teens, and how much to emphasize exercise with your own patients.

How do lithium and quetiapine compare in their ability to treat acute mania in children and teens? Are they effective? Do kids go into remission? And how do their side effect profiles compare?  This clinical update can help you decide which patients might be good candidates for which medication. 

You want to protect your manic child or teen patient from metabolic problems associated with most antipsychotics, so you think about using ziprasidone. How likely is it to work? Is it truly well tolerated? We give you our best take on it despite the problems inherent in industry-funded research. 

Deep Brain Stimulation is a surgically invasive procedure that is used in an attempt to treat several conditions including obsessive compulsive disorder in some youths. But does it work? Read our research update so you can better guide families on this high-risk decision.